We are live on ! Find out more
HCWB icon

HCW Biologics
HCWB

19 hedge funds and large institutions have $784K invested in HCW Biologics in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

0% more funds holding

Funds holding: 19 → 19 (0)

0% more ownership

Funds ownership: 0.01% → 0.01% (+0%)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

59% less capital invested

Capital invested by funds: $1.9M → $784K (-$1.11M)

Holders
19
Holders Change
–
Holders Change %
0%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
6
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
APP
Avantax Planning Partners
Iowa
+$123K
2
Citadel Advisors
Citadel Advisors
Florida
+$17.1K
3
Jane Street
Jane Street
New York
+$8.57K
4
UBS Group
UBS Group
Switzerland
+$4.43K
5
TRCT
Tower Research Capital (TRC)
New York
+$1.48K

Top Sellers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
-$7.98K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$4.73K
3
BlackRock
BlackRock
New York
-$4.14K
4
Bank of America
Bank of America
North Carolina
-$295
5
Wells Fargo
Wells Fargo
California
-$247
Name Holding Trade Value Shares
Change 		Change in
Stake
APP
1
Avantax Planning Partners
Iowa
$181K +$123K +416 +56%
HighTower Advisors
2
HighTower Advisors
Illinois
$117K +$1.18K +4 +0.5%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$110K -$4.73K -16 -2%
CAM
4
Cresset Asset Management
Illinois
$85.4K – – –
PIM
5
Pullen Investment Management
Florida
$55.1K – – –
BCM
6
Bridgeway Capital Management
Texas
$54.8K – – –
HF
7
HRT Financial
New York
$43K -$7.98K -27 -9%
BlackRock
8
BlackRock
New York
$27.6K -$4.14K -14 -7%
Vanguard Group
9
Vanguard Group
Pennsylvania
$24.4K – – –
AWM
10
AE Wealth Management
Kansas
$19.4K – – –
Jane Street
11
Jane Street
New York
$15.6K +$8.57K +29 +40%
Two Sigma Investments
12
Two Sigma Investments
New York
$14.5K – – –
State Street
13
State Street
Massachusetts
$13.9K – – –
Citadel Advisors
14
Citadel Advisors
Florida
$8.98K +$17.1K +58 New
Northern Trust
15
Northern Trust
Illinois
$6.6K – – –
TRCT
16
Tower Research Capital (TRC)
New York
$4.02K +$1.48K +5 +24%
UBS Group
17
UBS Group
Switzerland
$2.77K +$4.43K +15 +500%
Bank of America
18
Bank of America
North Carolina
$101 -$295 -1 -50%
Wells Fargo
19
Wells Fargo
California
– -$247 -1 Closed
JP Morgan Chase
20
JP Morgan Chase
New York
– -$15 – –
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
– +$295 +1 +100%

HCWB Hedge Fund Activity: Q2 2024 in Review

19 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in HCW Biologics (HCWB) for Q2 2024, worth a combined $784K — down 59% from $1.9M a quarter earlier.

Fund positioning in HCWB was balanced in Q2 2024: 1 fund opened new positions, 1 closed out, 6 added to existing stakes and 4 trimmed.

The largest buyer was Avantax Planning Partners, adding an estimated $123K. The largest seller was HRT Financial, cutting an estimated $7.98K.

  • 19 institutional investors held HCW Biologics (HCWB) as of Q2 2024, unchanged from Q1 2024.
  • Funds reported $784K of HCW Biologics stock for Q2 2024, down 59% quarter-over-quarter.
  • 1 fund opened new HCW Biologics positions in Q2 2024 and 1 closed out, a net change of 0 holders.
  • The largest HCW Biologics buyer in Q2 2024 was Avantax Planning Partners, an estimated $123K added.
  • The largest HCW Biologics seller in Q2 2024 was HRT Financial, an estimated $7.98K sold.

Based on aggregated 13F filings for Q2 2024.